These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 38074420)
1. Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19. Talebi T; Masoumi T; Heshmatzad K; Hesami M; Maleki M; Kalayinia S Genet Res (Camb); 2023; 2023():2593199. PubMed ID: 38074420 [TBL] [Abstract][Full Text] [Related]
2. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection. Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773 [TBL] [Abstract][Full Text] [Related]
3. Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study. Sienko J; Marczak I; Kotowski M; Bogacz A; Tejchman K; Sienko M; Kotfis K Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231922 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity. Huang SW; Wang SF Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729 [TBL] [Abstract][Full Text] [Related]
6. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
7. Saih A; Baba H; Bouqdayr M; Ghazal H; Hamdi S; Kettani A; Wakrim L Biomed Res Int; 2021; 2021():6685840. PubMed ID: 33884270 [TBL] [Abstract][Full Text] [Related]
9. Disparities in COVID-19 severities and casualties across ethnic groups around the globe and patterns of ACE2 and PIR variants. Shoily SS; Ahsan T; Fatema K; Sajib AA Infect Genet Evol; 2021 Aug; 92():104888. PubMed ID: 33933634 [TBL] [Abstract][Full Text] [Related]
10. Role of SARS-CoV-2 and ACE2 variations in COVID-19. Antony P; Vijayan R Biomed J; 2021 Jun; 44(3):235-244. PubMed ID: 34193390 [TBL] [Abstract][Full Text] [Related]
11. Mutations in spike protein and allele variations in ACE2 impact targeted therapy strategies against SARS-CoV-2. Shu CJ; Huang X; Tang HH; Mo DD; Zhou JW; Deng C Zool Res; 2021 Mar; 42(2):170-181. PubMed ID: 33738989 [TBL] [Abstract][Full Text] [Related]
12. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890 [TBL] [Abstract][Full Text] [Related]
13. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224 [TBL] [Abstract][Full Text] [Related]
14. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation. Huang SW; Miller SO; Yen CH; Wang SF Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
16. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. Zepeda-Cervantes J; Martínez-Flores D; Ramírez-Jarquín JO; Tecalco-Cruz ÁC; Alavez-Pérez NS; Vaca L; Sarmiento-Silva RE Viruses; 2022 Jan; 14(1):. PubMed ID: 35062298 [TBL] [Abstract][Full Text] [Related]
17. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction. Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG Elife; 2022 Nov; 11():. PubMed ID: 36416537 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
19. Human ACE2 Polymorphisms from Different Human Populations Modulate SARS-CoV-2 Infection. Hu P; Bauer VL; Sawyer SL; Diaz-Griffero F Viruses; 2022 Jun; 14(7):. PubMed ID: 35891433 [TBL] [Abstract][Full Text] [Related]
20. Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking. Badawi S; Mohamed FE; Alkhofash NR; John A; Ali A; Ali BR Hum Genomics; 2022 Sep; 16(1):35. PubMed ID: 36056420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]